IBDEI0LO ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,9752,2)
;;=^5019672
;;^UTILITY(U,$J,358.3,9753,0)
;;=N87.9^^39^417^35
;;^UTILITY(U,$J,358.3,9753,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9753,1,3,0)
;;=3^Dysplasia of Cervix Uteri,Unspec
;;^UTILITY(U,$J,358.3,9753,1,4,0)
;;=4^N87.9
;;^UTILITY(U,$J,358.3,9753,2)
;;=^5015877
;;^UTILITY(U,$J,358.3,9754,0)
;;=R30.0^^39^417^36
;;^UTILITY(U,$J,358.3,9754,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9754,1,3,0)
;;=3^Dysuria
;;^UTILITY(U,$J,358.3,9754,1,4,0)
;;=4^R30.0
;;^UTILITY(U,$J,358.3,9754,2)
;;=^5019322
;;^UTILITY(U,$J,358.3,9755,0)
;;=N92.1^^39^417^39
;;^UTILITY(U,$J,358.3,9755,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9755,1,3,0)
;;=3^Excessive/Frequent Menstruation w/ Irregular Cycle
;;^UTILITY(U,$J,358.3,9755,1,4,0)
;;=4^N92.1
;;^UTILITY(U,$J,358.3,9755,2)
;;=^5015909
;;^UTILITY(U,$J,358.3,9756,0)
;;=Z08.^^39^417^41
;;^UTILITY(U,$J,358.3,9756,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9756,1,3,0)
;;=3^F/U Exam After Malig Neop Treatment
;;^UTILITY(U,$J,358.3,9756,1,4,0)
;;=4^Z08.
;;^UTILITY(U,$J,358.3,9756,2)
;;=^5062667
;;^UTILITY(U,$J,358.3,9757,0)
;;=Z80.3^^39^417^42
;;^UTILITY(U,$J,358.3,9757,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9757,1,3,0)
;;=3^Family Hx of Breast CA
;;^UTILITY(U,$J,358.3,9757,1,4,0)
;;=4^Z80.3
;;^UTILITY(U,$J,358.3,9757,2)
;;=^5063347
;;^UTILITY(U,$J,358.3,9758,0)
;;=Z80.49^^39^417^43
;;^UTILITY(U,$J,358.3,9758,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9758,1,3,0)
;;=3^Family Hx of Genital Organ CA
;;^UTILITY(U,$J,358.3,9758,1,4,0)
;;=4^Z80.49
;;^UTILITY(U,$J,358.3,9758,2)
;;=^5063351
;;^UTILITY(U,$J,358.3,9759,0)
;;=Z80.41^^39^417^44
;;^UTILITY(U,$J,358.3,9759,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9759,1,3,0)
;;=3^Family Hx of Ovarian CA
;;^UTILITY(U,$J,358.3,9759,1,4,0)
;;=4^Z80.41
;;^UTILITY(U,$J,358.3,9759,2)
;;=^5063348
;;^UTILITY(U,$J,358.3,9760,0)
;;=N73.9^^39^417^47
;;^UTILITY(U,$J,358.3,9760,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9760,1,3,0)
;;=3^Female Pelvic Inflammatory Disease,Unspec
;;^UTILITY(U,$J,358.3,9760,1,4,0)
;;=4^N73.9
;;^UTILITY(U,$J,358.3,9760,2)
;;=^5015820
;;^UTILITY(U,$J,358.3,9761,0)
;;=N60.32^^39^417^48
;;^UTILITY(U,$J,358.3,9761,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9761,1,3,0)
;;=3^Fibrosclerosis,Left Breast
;;^UTILITY(U,$J,358.3,9761,1,4,0)
;;=4^N60.32
;;^UTILITY(U,$J,358.3,9761,2)
;;=^5015780
;;^UTILITY(U,$J,358.3,9762,0)
;;=N60.31^^39^417^49
;;^UTILITY(U,$J,358.3,9762,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9762,1,3,0)
;;=3^Fibrosclerosis,Right Breast
;;^UTILITY(U,$J,358.3,9762,1,4,0)
;;=4^N60.31
;;^UTILITY(U,$J,358.3,9762,2)
;;=^5015779
;;^UTILITY(U,$J,358.3,9763,0)
;;=Z01.411^^39^417^50
;;^UTILITY(U,$J,358.3,9763,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9763,1,3,0)
;;=3^GYN Exam w/ Abnormal Findings
;;^UTILITY(U,$J,358.3,9763,1,4,0)
;;=4^Z01.411
;;^UTILITY(U,$J,358.3,9763,2)
;;=^5062622
;;^UTILITY(U,$J,358.3,9764,0)
;;=Z01.419^^39^417^1
;;^UTILITY(U,$J,358.3,9764,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9764,1,3,0)
;;=3
;;^UTILITY(U,$J,358.3,9764,1,4,0)
;;=4^Z01.419
;;^UTILITY(U,$J,358.3,9764,2)
;;=^5062623
;;^UTILITY(U,$J,358.3,9765,0)
;;=Z01.419^^39^417^51
;;^UTILITY(U,$J,358.3,9765,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9765,1,3,0)
;;=3^GYN Exam w/ Normal Findings
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0LO 3767 printed Apr 09, 2024@21:00:50 Page 2
IBDEI0LO ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,9752,2)
+2 ;;=^5019672
+3 ;;^UTILITY(U,$J,358.3,9753,0)
+4 ;;=N87.9^^39^417^35
+5 ;;^UTILITY(U,$J,358.3,9753,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,9753,1,3,0)
+8 ;;=3^Dysplasia of Cervix Uteri,Unspec
+9 ;;^UTILITY(U,$J,358.3,9753,1,4,0)
+10 ;;=4^N87.9
+11 ;;^UTILITY(U,$J,358.3,9753,2)
+12 ;;=^5015877
+13 ;;^UTILITY(U,$J,358.3,9754,0)
+14 ;;=R30.0^^39^417^36
+15 ;;^UTILITY(U,$J,358.3,9754,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,9754,1,3,0)
+18 ;;=3^Dysuria
+19 ;;^UTILITY(U,$J,358.3,9754,1,4,0)
+20 ;;=4^R30.0
+21 ;;^UTILITY(U,$J,358.3,9754,2)
+22 ;;=^5019322
+23 ;;^UTILITY(U,$J,358.3,9755,0)
+24 ;;=N92.1^^39^417^39
+25 ;;^UTILITY(U,$J,358.3,9755,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,9755,1,3,0)
+28 ;;=3^Excessive/Frequent Menstruation w/ Irregular Cycle
+29 ;;^UTILITY(U,$J,358.3,9755,1,4,0)
+30 ;;=4^N92.1
+31 ;;^UTILITY(U,$J,358.3,9755,2)
+32 ;;=^5015909
+33 ;;^UTILITY(U,$J,358.3,9756,0)
+34 ;;=Z08.^^39^417^41
+35 ;;^UTILITY(U,$J,358.3,9756,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,9756,1,3,0)
+38 ;;=3^F/U Exam After Malig Neop Treatment
+39 ;;^UTILITY(U,$J,358.3,9756,1,4,0)
+40 ;;=4^Z08.
+41 ;;^UTILITY(U,$J,358.3,9756,2)
+42 ;;=^5062667
+43 ;;^UTILITY(U,$J,358.3,9757,0)
+44 ;;=Z80.3^^39^417^42
+45 ;;^UTILITY(U,$J,358.3,9757,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,9757,1,3,0)
+48 ;;=3^Family Hx of Breast CA
+49 ;;^UTILITY(U,$J,358.3,9757,1,4,0)
+50 ;;=4^Z80.3
+51 ;;^UTILITY(U,$J,358.3,9757,2)
+52 ;;=^5063347
+53 ;;^UTILITY(U,$J,358.3,9758,0)
+54 ;;=Z80.49^^39^417^43
+55 ;;^UTILITY(U,$J,358.3,9758,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,9758,1,3,0)
+58 ;;=3^Family Hx of Genital Organ CA
+59 ;;^UTILITY(U,$J,358.3,9758,1,4,0)
+60 ;;=4^Z80.49
+61 ;;^UTILITY(U,$J,358.3,9758,2)
+62 ;;=^5063351
+63 ;;^UTILITY(U,$J,358.3,9759,0)
+64 ;;=Z80.41^^39^417^44
+65 ;;^UTILITY(U,$J,358.3,9759,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,9759,1,3,0)
+68 ;;=3^Family Hx of Ovarian CA
+69 ;;^UTILITY(U,$J,358.3,9759,1,4,0)
+70 ;;=4^Z80.41
+71 ;;^UTILITY(U,$J,358.3,9759,2)
+72 ;;=^5063348
+73 ;;^UTILITY(U,$J,358.3,9760,0)
+74 ;;=N73.9^^39^417^47
+75 ;;^UTILITY(U,$J,358.3,9760,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,9760,1,3,0)
+78 ;;=3^Female Pelvic Inflammatory Disease,Unspec
+79 ;;^UTILITY(U,$J,358.3,9760,1,4,0)
+80 ;;=4^N73.9
+81 ;;^UTILITY(U,$J,358.3,9760,2)
+82 ;;=^5015820
+83 ;;^UTILITY(U,$J,358.3,9761,0)
+84 ;;=N60.32^^39^417^48
+85 ;;^UTILITY(U,$J,358.3,9761,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,9761,1,3,0)
+88 ;;=3^Fibrosclerosis,Left Breast
+89 ;;^UTILITY(U,$J,358.3,9761,1,4,0)
+90 ;;=4^N60.32
+91 ;;^UTILITY(U,$J,358.3,9761,2)
+92 ;;=^5015780
+93 ;;^UTILITY(U,$J,358.3,9762,0)
+94 ;;=N60.31^^39^417^49
+95 ;;^UTILITY(U,$J,358.3,9762,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,9762,1,3,0)
+98 ;;=3^Fibrosclerosis,Right Breast
+99 ;;^UTILITY(U,$J,358.3,9762,1,4,0)
+100 ;;=4^N60.31
+101 ;;^UTILITY(U,$J,358.3,9762,2)
+102 ;;=^5015779
+103 ;;^UTILITY(U,$J,358.3,9763,0)
+104 ;;=Z01.411^^39^417^50
+105 ;;^UTILITY(U,$J,358.3,9763,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,9763,1,3,0)
+108 ;;=3^GYN Exam w/ Abnormal Findings
+109 ;;^UTILITY(U,$J,358.3,9763,1,4,0)
+110 ;;=4^Z01.411
+111 ;;^UTILITY(U,$J,358.3,9763,2)
+112 ;;=^5062622
+113 ;;^UTILITY(U,$J,358.3,9764,0)
+114 ;;=Z01.419^^39^417^1
+115 ;;^UTILITY(U,$J,358.3,9764,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,9764,1,3,0)
+118 ;;=3
+119 ;;^UTILITY(U,$J,358.3,9764,1,4,0)
+120 ;;=4^Z01.419
+121 ;;^UTILITY(U,$J,358.3,9764,2)
+122 ;;=^5062623
+123 ;;^UTILITY(U,$J,358.3,9765,0)
+124 ;;=Z01.419^^39^417^51
+125 ;;^UTILITY(U,$J,358.3,9765,1,0)
+126 ;;=^358.31IA^4^2
+127 ;;^UTILITY(U,$J,358.3,9765,1,3,0)
+128 ;;=3^GYN Exam w/ Normal Findings
